Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

2661.95 (Glytoucan)

Id:652cfb3e-58e3-58a7-bf5f-670546203ac6

Glytoucan:G20178AP

Results found

Linked to

	Label	Description
	2661.95 has glycosequence GLYGEN.GLYCOSEQUENCE:G73775WR-GLYCOSEQ00174386 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2661.95 has glycosequence GLYGEN.GLYCOSEQUENCE:G91077AF-GLYCOSEQ00154953 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2661.95 has glycosequence GLYGEN.GLYCOSEQUENCE:G91077AF-GLYCOSEQ00154952 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2661.95 has canonical residue n-glycan a-d-neupnac 17 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2661.95 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000007 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2661.95 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000021 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2661.95 has canonical residue n-glycan a-d-neupnac 13 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2661.95 has glycosequence GLYGEN.GLYCOSEQUENCE:G01791IN-GLYCOSEQ00068666 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2661.95 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000060 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2661.95 has glycosequence GLYGEN.GLYCOSEQUENCE:G07091AK-GLYCOSEQ00042715 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2661.95 has glycosequence GLYGEN.GLYCOSEQUENCE:G73775WR-GLYCOSEQ00174386 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2661.95 has glycosequence GLYGEN.GLYCOSEQUENCE:G91077AF-GLYCOSEQ00154953 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2661.95 has glycosequence GLYGEN.GLYCOSEQUENCE:G91077AF-GLYCOSEQ00154952 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2661.95 has canonical residue n-glycan a-d-neupnac 17

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2661.95 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000007 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2661.95 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000021 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2661.95 has canonical residue n-glycan a-d-neupnac 13

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2661.95 has glycosequence GLYGEN.GLYCOSEQUENCE:G01791IN-GLYCOSEQ00068666 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2661.95 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000060 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2661.95 has glycosequence GLYGEN.GLYCOSEQUENCE:G07091AK-GLYCOSEQ00042715 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.